Bioequivalence Study Of Patent-Free Drugs-2 (In The Group Of Diseases Of The Central Nervous System)

Name: Bioequivalence Study Of Patent-Free Drugs-2 (In The Group Of Diseases Of The Central Nervous System)
Start: 2023-07-24
End: 2023-08-25
Location: AS GRINDEKS

AS GRINDEKS Latvia has Released a tender for Bioequivalence Study Of Patent-Free Drugs-2 (In The Group Of Diseases Of The Central Nervous System) in Building. The tender was released on Jul 24, 2023.

Country - Latvia

Summary - Bioequivalence Study Of Patent-Free Drugs-2 (In The Group Of Diseases Of The Central Nervous System)

Deadline - login to view

GT reference number - 69290064

Product classification - Building construction work

Organization Details:

Address - Latvia

Contact details - 565656565

Tender notice no. - 76454545

GT Ref Id - 69290064

Document Type - Tender Notices

Notice Details and Documents:

Description - Invitation for Bids: Bioequivalence Study Of Patent-Free Drugs-2 (In The Group Of Diseases Of The Central Nervous System) Buyer: AS GRINDEKS Deadline: 2023-08-25 Global Tenders is not only confined to tenders but we also upload crucial information, from future prospects to past market records.

Gt Ref Id - 69290064

Deadline - Aug 25, 2023

View more tenders for

Building construction work Tenders Latvia Tenders

Similar Tenders :

Create Account

Join to access thousands of business opportunities

Quick Links

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database